Methicillin-resistant Staphylococcus aureus: The European landscape

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue SUPPL. 4, 2011, Pages

  Johnson, Alan P ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Bacteraemia; MRSA; Staphylococcal infections; Surveillance

Indexed keywords

METICILLIN; PENICILLIN BINDING PROTEIN 2A;

BACTERIAL SKIN DISEASE; BACTERIAL TRANSMISSION; DRUG SURVEILLANCE PROGRAM; EUROPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL PATIENT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PNEUMONIA; PREVALENCE; REVIEW; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; SURGICAL INFECTION; SWINE DISEASE;

ANIMALS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EUROPE; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; ZOONOSES;

EID: 79955500873     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr076     Document Type: Review

References (52)

1. Rolinson GN. Forty years of beta-lactam research. J Antimicrob Chemother 1998; 41: 589-603.
2. Jevons MP. "Celbenin" -resistant Staphylococci. Br Med J 1961; 1: 124-5.
3. Grundmann H, Aires-de-Sousa M, Boyce J et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-85.
4. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005; 56: 455-62.
5. Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10: 1432-41.
6. Reynolds R. Antimicrobial resistance in the UK and Ireland. J Antimicrob Chemother 2009; 64 Suppl 1: i19-23.
7. European Centre for Disease Prevention and Control. EARSS Annual Reports. Available at http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/Documents.aspx (2 November 2010, date last accessed).
8. HPA. Voluntary reporting of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland, 2009. Available at http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1281952718651 (2 November 2010, date last accessed).
9. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009; 64 Suppl 1: i11-7.
10. Dryden M, Andrasevic AT, Bassetti M et al. A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 2010; 16 Suppl 1: 3-30.
11. Sader HS, Farrell DJ, Jones RN. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents 2010; 36: 28-32.
12. Health Protection Agency. Surveillance of Healthcare Associated Infections Report: 2008. Available at http://www.hpa.org.uk/Publications/InfectiousDiseases/AntimicrobialAndHealthcareAssociatedInfections/0807HCAIAnnualReport2008 (2 November 2010, date last accessed).
13. Health Protection Agency. Healthcare-associated infections and antimicrobial resistance: 2009/10. Available at http://www.hpa.org.uk/Publications/InfectiousDiseases/AntimicrobialAndHealthcareAssociatedInfections/1009Healthcareassocinfantimicrobialresistance200910 (2 November 2010, date last accessed).
14. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-87.
15. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009; 64: 441-6.
16. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74.
17. Ruppitsch W, Stoger A, Schmid D et al. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill 2007; 12: E071025.
18. Grisold AJ, Zarfel G, Stoeger A et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria. J Infect 2009; 58: 168-70.
19. Larsen AR, Stegger M, Bocher S et al. Emergence and characterization of community-associated methicillin-resistant Staphylococcus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009; 47: 73-8.
20. Kanerva M, Salmenlinna S, Vuopio-Varkila J et al. Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006. J Clin Microbiol 2009; 47: 2655-7.
21. Witte W, Strommenger B, Cuny C et al. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007; 60: 1258-63.
22. Witte W, Braulke C, Strommenger B. Community-associated methicillin-resistant Staphylococcus aureus ST8 ("USA300") in an HIV-positive patient in Cologne, Germany, February 2008. Euro Surveill 2008; 13. Available at http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=8080 (2 November 2010, date last accessed).
23. Valentini P, Parisi G, Monaco M et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 2008; 7: 11.
24. Marchese A, Gualco L, Maioli E et al. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones. Int J Antimicrob Agents 2009; 34: 424-8.
25. Baldan R, Tassan DC, Semeraro G et al. Severe community-onset infections in healthy individuals caused by community-acquired MRSA in an Italian teaching hospital, 2006-2008. J Hosp Infect 2009; 72: 271-3.
26. Huijsdens XW, Janssen M, Renders NH et al. Methicillin-resistant Staphylococcus aureus in a beauty salon, the Netherlands. Emerg Infect Dis 2008; 14: 1797-9.
27. Tavares DA, Sa-Leao R, Miragaia M et al. Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal. BMC Infect Dis 2010; 10: 110.
28. Manzur A, Dominguez AM, Pujol M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008; 14: 377-80.
29. Rodriguez-Bano J, Angeles DM, Blas MA et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococcus aureus in Spain. Clin Microbiol Infect 2009; 15: 1111-8.
30. Francois P, Harbarth S, Huyghe A et al. Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis 2008; 14: 304-7.
31. Otter JA, Havill NL, Boyce JM et al. Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: Where is USA300 in the UK? Eur J Clin Microbiol Infect Dis 2009; 28: 835-9.
32. Stenhem M, Ortqvist A, Ringberg H et al. Imported methicillin-resistant Staphylococcus aureus, Sweden. Emerg Infect Dis 2010; 16: 189-96.
33. Hunter PA, Dawson S, French GL et al. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother 2010; 65 Suppl 1: i3-17.
34. European Food Safety Authority. Analysis of the baseline survey on the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in holdings with breeding pigs, in the EU, 2008. Available at http://www.efsa.europa.eu/en/scdocs/scdoc/1376.htm (2 November 2010, date last accessed).
35. Huber H, Koller S, Giezendanner N et al. Prevalence and characteristics of meticillin-resistant Staphylococcus aureus in humans in contact with farm animals, in livestock, and in food of animal origin, Switzerland, 2009. Euro Surveill 2010; 15: 1-4. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19542 (2 November 2010, date last accessed).
36. Van Cleef BA, Broens EM, Voss A et al. High prevalence of nasal MRSA carriage in slaughterhouse workers in contact with live pigs in The Netherlands. Epidemiol Infect 2010; 138: 756-63.
37. Van Cleef BA, Verkade EJ, Wulf MW et al. Prevalence of livestock-associated MRSA in communities with high pig-densities in The Netherlands. PLoS One 2010; 5: e9385.
38. Denis O, Suetens C, Hallin M et al. Methicillin-resistant Staphylococcus aureus ST398 in swine farm personnel, Belgium. Emerg Infect Dis 2009; 15: 1098-101.
39. Aspiroz C, Lozano C, Vindel A et al. Skin lesion caused by ST398 and ST1 MRSA, Spain. Emerg Infect Dis 2010; 16: 157-9.
40. Pan A, Battisti A, Zoncada A et al. Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg Infect Dis 2009; 15: 845-7.
41. Krziwanek K, Metz-Gercek S, Mittermayer H. Methicillin-resistant Staphylococcus aureus ST398 from human patients, upper Austria. Emerg Infect Dis 2009; 15: 766-9.
42. Mammina C, Cala C, Plano MR et al. Ventilator-associated pneumonia and MRSA ST398, Italy. Emerg Infect Dis 2010; 16: 730-1.
43. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
44. Frenay HM, Bunschoten AE, Schouls LM et al. Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996; 15: 60-4.
45. Johnson AP, Aucken HM, Cavendish S et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001; 48: 143-4.
46. Ellington MJ, Hope R, Livermore DM et al. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 2010; 65: 446-8.
47. Grundmann H, Aanensen DM, van den Wijngaard CC et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010; 7: e1000215.
48. Donker T, Wallinga J, Grundmann H. Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput Biol 2010; 6: e1000715.
49. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes-what's missing? J Antimicrob Chemother 2010; 65: 2275-7.
50. Bjorholt I, Haglind E. Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital. Eur J Clin Microbiol Infect Dis 2004; 23: 688-95.
51. van Rijen MM, Kluytmans JA. Costs and benefits of the MRSA search and destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis 2009; 28: 1245-52.
52. Vander Stichele RH, Elseviers MM, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.